Who Exports Pyrantel from India — 70 Suppliers Behind a $3.3M Market
India's pyrantel export market is supplied by 70 active exporters who collectively shipped $3.3M across 477 shipments. KUSUM HEALTHCARE PRIVATE LIMITED leads with a 22.5% market share, followed by IPCA LABORATORIES LIMITED and OXFORD LABORATORIES PRIVATE LIMITED. The top 5 suppliers together control 75.2% of total export value, reflecting a concentrated market structure.
Top Pyrantel Exporters from India — Ranked by Export Value
KUSUM HEALTHCARE PRIVATE LIMITED is the leading pyrantel exporter from India, holding a 22.5% share of the $3.3M market across 477 shipments from 70 exporters. The top 5 suppliers — KUSUM HEALTHCARE PRIVATE LIMITED, IPCA LABORATORIES LIMITED, OXFORD LABORATORIES PRIVATE LIMITED, SAVA HEALTHCARE LIMITED, MEPRO PHARMACEUTICALS PRIVATE LIMITED — collectively control 75.2% of total export value, indicating a highly concentrated market. Individual shares are: KUSUM HEALTHCARE PRIVATE LIMITED (22.5%), IPCA LABORATORIES LIMITED (19.5%), OXFORD LABORATORIES PRIVATE LIMITED (16.5%), SAVA HEALTHCARE LIMITED (11.7%), MEPRO PHARMACEUTICALS PRIVATE LIMITED (5.1%).
Top Pyrantel Exporters from India
Ranked by export value · 70 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | KUSUM HEALTHCARE PRIVATE LIMITED PYRANTEL TABLETS 10X3S(PYRANTEL 250 MGPYRANTEL TABLETS 10X3S(PYRANTEL 250 MG TPYRANTEL TABLETS 10X3SBNO.1005408,DOM11.2024,DOE10.2027 | $736.8K | 2 | 22.5% |
| 2 | IPCA LABORATORIES LIMITED PYRANTEL PAMOATE ORAL SUSPENSION 15 MLPYRANTEL PAMOATE TABLET-250 MG(OTHER DETAILSNOSPYRANTEL PAMOATE ORAL SUSPENSION USP 250MG | $637.0K | 3 | 19.5% |
| 3 | OXFORD LABORATORIES PRIVATE LIMITED PYRANTEL PAMOATE ORAL SUSPENSION 15 MLPYRANTEL PAMOATE TABLET-250 MG(OTHER DETAILSNOSPYRANTEL PAMOATE ORAL SUSPENSION USP 250MG | $539.4K | 6 | 16.5% |
| 4 | SAVA HEALTHCARE LIMITED PYRANTEL PAMOATE TABLETS -PYRANTEL PAMOATE TABLETS EACH UNCOATED TPYRANTEL PAMOATE TABLETS AS PER INVOICE& PACKING LISTNOS | $382.1K | 3 | 11.7% |
| 5 | MEPRO PHARMACEUTICALS PRIVATE LIMITED PHARMACEUTICAL PRODUCTS: COMBAVERS TABLETS QTY:100370X1X6'S | $166.6K | 3 | 5.1% |
| 6 | DEEPA INTERNATIONAL PHARMACEUTICAL PRODUCTS: COMBAVERS TABLETS QTY:100370X1X6'S | $88.8K | 4 | 2.7% |
| 7 | VARDHMAN EXPORTS PYRATRIN TABLETS 1X6S NOSPYRATRIN TABLETS 1X6S (PYRANTEL PAMOATEPYRAMOATE SUSPENSION 10ML (PYRANTEL PAMO | $80.9K | 1 | 2.5% |
| 8 | ASHISH LIFE SCIENCE PRIVATE LIMITED PYRATRIN TABLETS 1X6S NOSPYRATRIN TABLETS 1X6S (PYRANTEL PAMOATEPYRAMOATE SUSPENSION 10ML (PYRANTEL PAMO | $56.4K | 7 | 1.7% |
| 9 | ZENEX ANIMAL HEALTH INDIA PRIVATE LIMITED | $40.8K | 2 | 1.2% |
| 10 | S.D.PHARMACEUTICALS PYRANTEL PAMOATE TABLETS 250MG | $39.3K | 1 | 1.2% |
| 11 | ALFA BIOMED INDIA PRIVATE LIMITED | $38.7K | 2 | 1.2% |
| 12 | SAI PARENTERALS PRIVATE LIMITED | $30.8K | 1 | 0.9% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Pyrantel exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| KUSUM HEALTHCARE PRIVATE LIMITED | Not Listed | Yes (Certified as of | No | Not verified | WHO-GMP certification confirmed by CDSCO as of November 2025. |
| IPCA LABORATORIES LIMITED | Not Listed | Yes (Certified as of | No | Not verified | WHO-GMP certification confirmed by CDSCO as of November 2025. |
| MEPRO PHARMACEUTICALS PRIVATE LIMITED | Not Listed | Yes (Certified as of | No | Not verified | WHO-GMP certification confirmed by CDSCO as of November 2025. |
| ASHISH LIFE SCIENCE PRIVATE LIMITED | Not Listed | Yes (Certified as of | No | Not verified | WHO-GMP certification confirmed by CDSCO as of November 2025. |
| ZENEX ANIMAL HEALTH INDIA PRIVATE LIMITED | Not Listed | Yes (Certified as of | No | Not verified | WHO-GMP certification confirmed by CDSCO as of November 2025. |
| S.D. PHARMACEUTICALS | Not Listed | Yes (Certified as of | No | Not verified | WHO-GMP certification confirmed by CDSCO as of November 2025. |
| ALFA BIOMED INDIA PRIVATE LIMITED | Not Listed | Yes (Certified as of | No | Not verified | WHO-GMP certification confirmed by CDSCO as of November 2025. |
| SAI PARENTERALS PRIVATE LIMITED | Not Listed | Yes (Certified as of | No | Not verified | WHO-GMP certification confirmed by CDSCO as of November 2025. |
TransData Nexus reviewed the regulatory standing of 8 leading Pyrantel exporters from India. 0 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Pyrantel sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for active pharmaceutical ingredients (APIs). The city hosts over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. Its advanced R&D infrastructure and skilled workforce make it a prime location for API production. Given Pyrantel's classification as an API, Hyderabad's capabilities are well-suited for its manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production, with companies like Zydus Cadila and Torrent Pharmaceuticals headquartered here. This region's focus on formulations positions it as a strategic location for producing Pyrantel-based finished dosage forms.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceuticals. Mumbai, being India's financial capital, offers robust infrastructure and connectivity, facilitating efficient distribution of pharmaceutical products globally. Companies like Ipca Laboratories, a significant exporter of Pyrantel, are based in this region, underscoring its importance in the export supply chain.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in Himachal Pradesh, is Asia's largest pharmaceutical hub, housing over 1,000 manufacturing units. The region's growth has been propelled by favorable government policies, including tax incentives, making it an attractive destination for pharmaceutical manufacturing. Its strategic location and infrastructure support large-scale production, which can be advantageous for Pyrantel manufacturing.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Leverage Regional Specializations: Source APIs from Hyderabad for their expertise in bulk drug production and formulations from Gujarat for their proficiency in finished dosage forms.
- Optimize Logistics: Utilize the Mumbai-Thane-Raigad region's export infrastructure to streamline global distribution channels.
- Evaluate Cost Benefits: Consider manufacturing in Baddi to take advantage of tax incentives and cost-effective production capabilities.
By strategically aligning sourcing and manufacturing activities with the strengths of these pharmaceutical clusters, TransData Nexus can enhance its supply chain efficiency and resilience for Pyrantel production and distribution.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Pyrantel exporters from India
Ipca Laboratories Limited — Ipca Laboratories acquires Unichem Laboratories Ltd.
On August 2, 2023, Ipca Laboratories Limited completed the acquisition of Unichem Laboratories Ltd., enhancing its product portfolio and market reach. IMPACT: This acquisition is expected to strengthen Ipca's position in the Pyrantel export market by expanding its manufacturing capabilities and distribution network.
Impact: This acquisition is expected to strengthen Ipca's position in the Pyrantel export market by expanding its manufacturing capabilities and distribution network.
Ipca Laboratories Limited — Ipca Laboratories invests in Lyka Labs Ltd.
As of March 31, 2024, Ipca Laboratories Limited made a strategic investment in Lyka Labs Ltd., aiming to bolster its pharmaceutical manufacturing and research capabilities. IMPACT: This investment is anticipated to enhance Ipca's production capacity for Pyrantel, potentially increasing export volumes.
Impact: This investment is anticipated to enhance Ipca's production capacity for Pyrantel, potentially increasing export volumes.
Ipca Laboratories Limited — Ipca Laboratories acquires Trophic Wellness Pvt. Ltd.
On March 31, 2024, Ipca Laboratories Limited acquired Trophic Wellness Pvt. Ltd., expanding its product offerings in the wellness and nutraceutical segments. IMPACT: While primarily focused on wellness products, this acquisition may indirectly support Ipca's Pyrantel exports through enhanced research and development capabilities.
Impact: While primarily focused on wellness products, this acquisition may indirectly support Ipca's Pyrantel exports through enhanced research and development capabilities.
Common Questions — Pyrantel Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which pyrantel supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, KUSUM HEALTHCARE PRIVATE LIMITED leads with 27 recorded shipments worth $736.8K. IPCA LABORATORIES LIMITED (57 shipments) and OXFORD LABORATORIES PRIVATE LIMITED (27 shipments) are also established high-volume exporters.
Q How many pyrantel manufacturers are there in India?
India has 70 active pyrantel exporters with a combined export market of $3.3M across 477 shipments to 54 countries. The top 5 suppliers hold 75.2% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for pyrantel from India?
Average FOB unit price: $6.69 per unit, ranging from $0.01 to $762.66. Average shipment value: $6.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 70 verified Indian exporters of Pyrantel ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 477 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 54 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
477 Verified Shipments
70 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists